About MatTek
MatTek is a company based in Ashland (United States) founded in 1985 was acquired by Sartorius in April 2025. The company has 68 employees. MatTek offers products and services including EpiAirway, EpiDerm, EpiOcular, EpiIntestinal, and Primary Cells and Media. MatTek operates in a competitive market with competitors including Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
Products & Services of MatTek
MatTek offers a comprehensive portfolio of products and services, including EpiAirway, EpiDerm, EpiOcular, EpiIntestinal, and Primary Cells and Media.
In vitro model for airway tissue research and toxicology
Model for skin irritation and corrosion testing
Platform for eye irritation studies
Model for intestinal drug delivery research
Cells and media for cell culture applications
Funding Insights of MatTek
- Total Rounds 26
- Last Round Grant — $252,129
- First Round $1.56M
(Jun 2004)
- Investors Count 1
Latest 10 of 26 funding rounds of MatTek with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $252,129 | Grant | – | – | |
| Jun 2019 | $448,936 | Grant | – | – | |
| Jun 2014 | $1.55M | Grant | – | – | |
| Jun 2013 | $440,352 | Grant | – | – | |
| Jun 2011 | $1.76M | Grant | – | – | |
| Dec 2010 | $835,982 | Grant | – | – | |
| Dec 2010 | $977,640 | Grant | – | – | |
| Sep 2010 | $267,914 | Grant | – | – | |
| Aug 2010 | $2.15M | Grant | – | – | |
| Jun 2010 | $267,914 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in MatTek
MatTek has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Sartorius, HHS and CELLINK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany | |
3D bioprinters and bioinks are developed for research applications. | 2016 | cellink.com | Boston, United States |
Investor details for MatTek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MatTek
11 people are tracked at MatTek (4 in leadership, 7 in team); the tracked headcount is 68.
| Name | Role | Group |
|---|---|---|
Mitchell Klausner | CEO & President | Leadership |
Jennifer Molignano | Scientist/Study Director | Leadership |
Christian Pellevoisin | Scientific Director | Leadership |
Alex Armento | Head Of Mattek | Leadership |
Olivia Gabriel | Production Associate II / Research Associate I | Team |
Camden H. | Research Associate I | Team |
Dylan Bryda | Associate Scientist | Team |
Mateo Frare | Associate Scientist, Research & Development | Team |
Kaitlyn Coen | Production Laboratory Manager/ Scientist | Team |
Marek Puskar | Production Manager and Junior Scientist | Team |
Kalyani Guntur | Senior Scientist | Team |
Complete people profiles for MatTek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of MatTek
MatTek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| arbor.bio | 2016 | Cambridge, United States | $304.1M | 117 | Genomic technologies and drug discovery platforms are provided. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| relaytx.com | 2016 | Cambridge, United States | $520M | 261 | Drug discovery platform is developed to study protein motion. | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of MatTek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MatTek
The website of MatTek (mattek.com) receives about 17.4K visits a month.
- Monthly visits17.4K
▲ 22.3% vs previous month
Websites whose visitors overlap most with MatTek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
genzymebiosurgery.com | genzymebiosurgery.com | 100% | – | – | – |
ptei.org | ptei.org | 100% | – | – | – |
| rtix.com | 100% | – | #10,270,241 | View details | |
minucells.com | minucells.com | 100% | – | – | – |
tissue-engineering.de | tissue-engineering.de | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for MatTek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Mattek
Complete news archive for MatTek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to MatTek
10 companies that operate in the same segment as MatTek (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MatTek
MatTek was founded in 1985 and raised its 1st funding round 19 years after it was founded.
MatTek is headquartered in Ashland, United States. It is registered at Ashland, Oregon, United States.
Mitchell Klausner is the current CEO of MatTek.
MatTek has 68 employees.
MatTek was founded in 1985 in Ashland, United States, as a biotechnology firm specializing in human cell-based tissue engineering. Operations center on creating and marketing 3D models for dermatology, immunology, toxicology, and applications in respiratory, ocular, oral, intestinal, and vaginal tissues. Validated products such as EpiDerm and EpiAirway support drug development and irritation testing. Primary cells, cell lines, media, and labware are also provided.
MatTek's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
MatTek offers EpiAirway, EpiDerm, EpiOcular, EpiIntestinal, and Primary Cells and Media.
Yes. MatTek was acquired by Sartorius in April 2025.